Black_cats
ELITE MEMBER
- Joined
- Dec 31, 2010
- Messages
- 10,031
- Reaction score
- -5
Indian ban on vaccine export won’t hamper Bangladesh deal: minister
Staff Correspondent | Published: 14:16, Jan 04,2021 | Updated: 14:17, Jan 04,2021
Health minister Zahid Maleque
Health minister Zahid Maleque said on Monday that the Bangladesh government was expecting the Indian government’s ban on export of COVID-19 vaccine by the Serum Institute of India would not hamper the tripartite agreement with Bangladesh.
Speaking at a press conference on the back of news that India would not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the minister said that they contacted Indian sources and it was still no matter of despair about getting the vaccines from the Serum.
‘After getting the news, we have contacted Indian high commission and foreign ministry is in touch with their Indian counterpart. So far what we have learnt is that there is nothing to be worried about the vaccine supply,’ he said.
Zahid Maleque, however, said the latest development left them in dark about when the vaccine would arrive in Bangladesh.
Bangladesh was earlier expecting to get the first consignment of the vaccine in January last week or February.
Related Coverage:
‘We’ll let you know after getting the proper development in three to four days,’ he said.
The government has a contract with Serum Institute of India to procure three crore doses of the Oxford-AstraZeneca COVID-19 vaccine through its local vendor Beximco Pharmaceuticals for 1.5 crore people.
Serum chief executive officer Adar Poonawalla to reporters in India on Sunday that Indian regulators authorised the emergency use of the vaccine on the condition that the company would not export it for several months.
According to the tripartite contract, signed by the health ministry on November 5 without any tender with Serum and Beximco for buying the quantity, the government will pay for each of the doses $5, including $4 as price and $1 for carrying it maintaining the required temperature, at least one dollar higher than the price announced by AstraZeneca for each dose recently.
Serum Institute will pay its local agent Beximco Pharma for carrying the vaccines from the former’s warehouse to the Bangladesh government’s warehouse as per the deal, said, officials.
www.newagebd.net
Staff Correspondent | Published: 14:16, Jan 04,2021 | Updated: 14:17, Jan 04,2021
Health minister Zahid Maleque
Health minister Zahid Maleque said on Monday that the Bangladesh government was expecting the Indian government’s ban on export of COVID-19 vaccine by the Serum Institute of India would not hamper the tripartite agreement with Bangladesh.
Speaking at a press conference on the back of news that India would not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the minister said that they contacted Indian sources and it was still no matter of despair about getting the vaccines from the Serum.
‘After getting the news, we have contacted Indian high commission and foreign ministry is in touch with their Indian counterpart. So far what we have learnt is that there is nothing to be worried about the vaccine supply,’ he said.
Zahid Maleque, however, said the latest development left them in dark about when the vaccine would arrive in Bangladesh.
Bangladesh was earlier expecting to get the first consignment of the vaccine in January last week or February.
Related Coverage:
‘We’ll let you know after getting the proper development in three to four days,’ he said.
The government has a contract with Serum Institute of India to procure three crore doses of the Oxford-AstraZeneca COVID-19 vaccine through its local vendor Beximco Pharmaceuticals for 1.5 crore people.
Serum chief executive officer Adar Poonawalla to reporters in India on Sunday that Indian regulators authorised the emergency use of the vaccine on the condition that the company would not export it for several months.
According to the tripartite contract, signed by the health ministry on November 5 without any tender with Serum and Beximco for buying the quantity, the government will pay for each of the doses $5, including $4 as price and $1 for carrying it maintaining the required temperature, at least one dollar higher than the price announced by AstraZeneca for each dose recently.
Serum Institute will pay its local agent Beximco Pharma for carrying the vaccines from the former’s warehouse to the Bangladesh government’s warehouse as per the deal, said, officials.
Indian ban on vaccine export won’t hamper Bangladesh deal: minister
Health minister Zahid Maleque said on Monday that the Bangladesh government was expecting the Indian government’s ban on export of COVID-19 vaccine by the Serum...
www.newagebd.net
